Wednesday, September 15, 2021 MEC4 Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target. Bao R, Surriga O, Olson DJ, Allred JB, Strand CA, Zha Y, Carll T, Labadie BW, Bastos BR, Butler M, Hogg D, Musi E, Ambrosini G, Munster P, Schwartz GK, Luke JJ. Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target. Melanoma Research 31: 27-37, 2021. https://journals.lww.com/melanomaresearch/Fulltext/2021/02000/Transcriptional_analysis_of_metastatic_uveal.3.aspx EN7 Relationship with Histotype, Molecular Classification, and Clinical Outcomes. Vermij L, Horeweg N, Leon-Castillo A, Rutten TA, Mileshkin LR, Mackay HJ, Leary A, Powell ME, Singh N, Crosbie EJ, Smit VTHB, Creutzberg CL, Bosse T. HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes. Cancers (Basel) 13: 44, 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795222/
